Today, the Minister of Health of the Republic of Kazakhstan Akmaral Alnazarova visited SK-Pharmaceuticals, where she got acquainted with the current activities of the company.
As part of the meeting, which was attended by representatives of the Ministry of Health and its subordinate organizations, key issues related to providing the population with medicines and medical products were discussed.
At the meeting, the Minister touched upon a number of important issues related to logistics, timely delivery of medicines, compliance with the "cold chain" during transportation, as well as ensuring the availability of medicines for all categories of the population.
"Ensuring the transparency of distribution and timely delivery of medicines is one of the key priorities of the Ministry. The management of SK-Pharmaceuticals needs to develop measures to improve the effectiveness of interaction with regional medical organizations," Akmaral Alnazarova emphasized.
Representatives of the Unified Distributor reported on the progress of the implementation of the Roadmap aimed at eliminating the causes and conditions contributing to corruption offenses, as well as optimizing procurement processes and improving the distribution system.
Managing Director and Member of the Board of Directors of SK-Pharmaceuticals LLP Ruslan Nurmukhan noted: “In recent years, there has been a trend towards increasing cost savings in the drug supply system. This result is achieved thanks to centralized procurement through the Single Distributor. Every year, about 2 million patients are provided with equally high-quality drugs at the same price. Procurement for 2 thousand medical organizations is centralized. We are currently working on issues of improving regulatory legal acts and digitizing all business processes, taking into account the planning of procurement, storage, transportation of medicines and other aspects.” The Minister emphasized the need to further improve the processes related to supplies and instructed the management of SK-Pharmaceuticals LLP to develop specific measures to increase the efficiency and transparency of distribution. Following the meeting, specific instructions were given to strengthen interaction with regional medical organizations and speed up the process of delivering the necessary medicines to medical institutions.
